PYXS vs TECH · rev $2.8M vs P/E 65, rev $1.22B
Pyxis Oncology Inc (PYXS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
PYXS currently screens at market cap $109.6M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the PYXS and TECH stock pages for the full models.
Not investment advice.